Dr. Patel is a Professor of Medicine and Consultant Hepatologist at UHN Toronto. He received his Medical degree from the University of Southampton, United Kingdom, and completed his Gastroenterology/Hepatology training in Australia. He completed his DM and PhD postgraduate degrees, and his Clinical and Translational Research fellowship in viral hepatitis at Scripps Clinic and Research Foundation, San Diego and Duke Clinical Research Institute, Durham, North Carolina. He was on Faculty at Duke University from 2004 until relocating to University of Toronto in 2016. His research interests include early clinical therapeutics for MASLD and non-invasive biomarkers of fibrosis.

I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Member of an advisory board or speakers’ bureau: Advisory: NovoNordisk, Merck, Boehringer-Ingelheim, Inipharm Data committee: Gilead, Bausch
- Currently participating, or have participated, in a clinical trial within the past two years: Gilead Sciences, Madrigal, GSK, Merck, 89 Bio, Akero
- Received/will receive a grant or an honorarium from a for-profit or not-for-profit organization: Novonordisk (grant)

I intend to make therapeutic recommendations for medications that have not received regulatory approval (ie, “off-label” use of medications).